pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 17·1 min read
save

Hackers claim to have stolen Novo Nordisk AI models and drug manufacturing recipes, demand $25M ransom

Jun 17, 2026·read at Endpoints ↗Negative

Novo Nordisk disclosed that a hacker group says it has obtained the company's proprietary AI models and manufacturing recipes for its drugs.

The group alleges the data is for sale and has demanded a ransom, reportedly $25 million, though Novo Nordisk has not confirmed any payment.

The breach underscores rising cyber‑risk for biotech firms and may lead to tighter security measures, but no immediate impact on drug supply has been reported.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Hackers claim they stole Novo Nordisk AI models, manufacturing recipes”

read at Endpoints ↗
87 words · retrieved Jun 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVO6Novo Nordisk Inc4RISING

related stories

  • Sep 28Trump uses ‘contested’ power to cut more funding to HHSSTAT
  • Sep 22Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030BioSpace
  • Sep 21STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer workSTAT
  • Sep 9Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and MarketsBioSpace
  • Aug 21‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing itFierce Biotech